Health Catalyst, Inc.
HCAT · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.54 | -0.14 | -1.92 |
| FCF Yield | -3.34% | -0.13% | -1.90% | 0.36% |
| EV / EBITDA | -17.15 | -95.33 | -238.88 | -78.43 |
| Quality | ||||
| ROIC | -7.11% | -2.59% | -2.35% | -1.83% |
| Gross Margin | 47.37% | 45.63% | 43.58% | 44.58% |
| Cash Conversion Ratio | 0.02 | 0.22 | -0.01 | 0.17 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.91% | 3.56% | 3.34% | 3.54% |
| Free Cash Flow Growth | -2,147.95% | 95.33% | -566.26% | 166.02% |
| Safety | ||||
| Net Debt / EBITDA | -5.44 | -15.52 | -61.42 | -5.35 |
| Interest Coverage | -6.41 | -2.76 | -2.40 | -2.23 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 57.30 | 53.94 | 41.74 | 30.51 |